Essential tremor

Last updated
Essential tremor
Other namesIdiopathic tremor
Spiral drawing of Essential Tremor patient.svg
Archimedean spiral drawings from a man with a unilateral essential tremor. The spiral on the left was drawn by the subject using the left hand, and the one on the right using the right hand.
Specialty Neurology
Usual onsetAny age, but typically after 40
CausesUnknown
Risk factors Family history, exposure to particular toxins [1]
Diagnostic method Based on symptoms [2]
Differential diagnosis Cerebellar tremor, dystonic tremor, multiple sclerosis, Parkinson's disease [3]
TreatmentMedications, surgery [4]
Medication Beta blockers, primidone, anti-epileptics, topiramate, gabapentin, levetiracetam, benzodiazepines [4]
FrequencyAnnual incidence of 23.7 per 100,000 (2010) [5]

Essential tremor (ET), also called benign tremor, familial tremor, and idiopathic tremor, is a medical condition characterized by involuntary rhythmic contractions and relaxations (oscillations or twitching movements) of certain muscle groups in one or more body parts of unknown cause. [6] It is typically symmetrical, and affects the arms, hands, or fingers; but sometimes involves the head, vocal cords, or other body parts. [4] Essential tremor is either an action (intention) tremor—it intensifies when one tries to use the affected muscles during voluntary movements such as eating and writing—or it is a postural tremor, present with sustained muscle tone. This means that it is distinct from a resting tremor, such as that caused by Parkinson's disease, which is not correlated with movement. [7]

Contents

Essential tremor is a progressive [8] [9] [10] neurological disorder, and the most common movement disorder. Its onset is usually after age 40, but it can occur at any age.[ medical citation needed ] The cause is unknown. Diagnosis is by observing the typical pattern of the tremor coupled with the exclusion of known causes of such a tremor.

While essential tremor is distinct from Parkinson's disease, which causes a resting tremor, essential tremor is nevertheless sometimes misdiagnosed as Parkinson's disease. [4] Some patients have been found to have both essential tremors and resting tremors. [4]

Treatments for essential tremor include medications, typically given sequentially to determine which provides the best compromise between effectiveness and troublesome side effects. Clostridium botulinum toxin (Botox) injections and ultrasound are also sometimes used for cases refractory to medications.

Signs and symptoms

In mild cases, ET can manifest as the inability to stop the tongue or hands from shaking, the ability to sing only in vibrato, and difficulty doing small, precise tasks such as threading a needle. Even simple tasks such as cutting in a straight line or using a ruler can range from difficult to impossible, depending on the severity of the condition. In disabling cases, ET can interfere with a person's activities of daily living, including feeding, dressing, and taking care of personal hygiene. Essential tremor generally presents as a rhythmic tremor (4–12 Hz) that occurs only when the affected muscle is exerting effort. Any sort of physical or mental stress tends to make the tremor worse. [2]

The tremor may also occur in the head (neck), jaw, and voice, as well as other body regions, with the general pattern being that the tremor begins in the arms and then spreads to these other regions in some people. Women are more likely to develop the head tremor than are men. Other types of tremor may also occur, including postural tremor of the outstretched arms, intention tremor of the arms, and rest tremor in the arms. [11] Some people may have unsteadiness and problems with gait and balance. [12]

ET-related tremors do not occur during sleep, but people with ET sometimes complain of an especially coarse tremor upon awakening that becomes noticeably less coarse within the first few minutes of wakefulness. Tremor and disease activity can intensify in response to fatigue, strong emotions, low blood sugar, cold and heat, caffeine, lithium salts, some antidepressants, stress, and other factors. [13]

Parkinson's disease and parkinsonism can also occur simultaneously with ET. [4] The degree of tremor, rigidity, and functional disability did not differ from patients with idiopathic Parkinson's disease. Hand tremor predominated (as it did in Parkinson's disease), and occurred in nearly all cases, followed by head tremor, voice tremor, neck, face, leg, tongue, and trunk tremor. Most other tremors occurred in association with hand tremor. More severe tremors, a lower sleep disorder frequency, and a similar prevalence of other non-motor symptoms also can occur. [14]

Walking difficulties in essential tremor are common. About half of patients have associated dystonia, including cervical dystonia, writer's cramp, spasmodic dysphonia, and cranial dystonia, and 20% of the patients had associated parkinsonism. Olfactory dysfunction (loss of sense of smell) is common in Parkinson's disease, and has also been reported to occur in patients with essential tremor. A number of patients with essential tremor also exhibit many of the same neuropsychiatric disturbances seen in idiopathic Parkinson's disease. [15]

Essential tremor with tremor onset after the age of 65 has been associated with mild cognitive impairment, [16] as well as dementia, although the link between these conditions, if any, is still not understood. [17] [18]

Essential tremor has two tremor components, central and peripheral. These two tremor components were identified by measuring the tremor of ET patients once with no weights on their hands and then with 1-pound weights on their hands. The addition of the weights resulted in a tremor spectrum with two peaks, one that maintained the same frequency (the central tremor) and one that decreased in frequency (the peripheral tremor). Only with the addition of the weights was the peripheral tremor distinguishable from the central tremor. [19]

The frequency of essential tremor is 4 to 11 Hz, depending on which body segment is affected. Proximal segments are affected at lower frequencies, and distal segments are affected at higher frequencies. [20]

Cause

Genetic

The underlying cause of essential tremor is not clear, but many cases seem to be familial. [21] About half of the cases are due to a genetic mutation and the pattern of inheritance is most consistent with autosomal dominant transmission. No genes have been identified yet, but genetic linkage has been established with several chromosomal regions. [22] [23]

Toxins

Some environmental factors, including toxins, are also under active investigation, as they may play a role in the disease's cause. [24]

Pathophysiology

In terms of pathophysiology, clinical, physiological and imaging studies point to an involvement of the cerebellum and/or cerebellothalamocortical circuits. [25] Changes in the cerebellum could also be mediated by alcoholic beverage consumption. Purkinje cells are especially susceptible to ethanol excitotoxicity. [26] Impairment of Purkinje synapses is a component of cerebellar degradation that could underlie essential tremor. [26] Some cases have Lewy bodies in the locus ceruleus. [27] [28] [29] ET cases that progress to Parkinson's disease are less likely to have had cerebellar problems. [30] Recent neuroimaging studies [31] have suggested that the efficiency of the overall brain functional network in ET is disrupted.

In 2012, the National Toxicology Program concluded that sufficient evidence exists of an association between blood lead exposure at levels >10 μg/dl and essential tremor in adults, and limited evidence at blood lead levels >5 μg/dl. [32]

Genetics

Recent post mortem studies have evidenced alterations in leucine-rich repeat and Ig domain containing one ( LINGO1 ) gene [33] [34] and GABA receptors [35] in the cerebellum of people with essential tremor. HAPT1 mutations have also been linked to ET, as well as to Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. [36]

Diagnosis

Usually, the diagnosis is established on clinical grounds. Tremors can start at any age, from birth through advanced ages (senile tremor). [37] [38] Any voluntary muscle in the body may be affected, although the tremor is most commonly seen in the hands and arms and slightly less commonly in the neck (causing the person's head to shake), tongue, and legs. A resting tremor of the hands is sometimes present. [15] [39] Tremor occurring in the legs might be diagnosable as orthostatic tremor.

ET occurs within multiple neurological disorders besides Parkinson's disease. This includes migraine disorders, where co-occurrences between ET and migraines have been examined. [40]

Treatment

General measures

Not all individuals with ET require treatment, but many treatment options are available depending on symptom severity. [4] Caffeine and stress should be avoided, and adequate good-quality sleep is recommended. [4]

Oral medications

First-line

When symptoms are sufficiently troublesome to warrant treatment, the first medication choices are beta blockers, such as propranolol or alternately, nadolol and timolol. Atenolol and pindolol are not effective for tremor. [4] Sotalol has shown some potential efficacy, but this remains an off-label use. [41] The anticonvulsant primidone may also be effective. [4] ET is generally very responsive to alcohol, but the risks of regular drinking are greater than the potential benefit. Nonetheless, ET patients sometimes self-medicate with alcohol. [42]

Propranolol and primidone only have tremor-reducing effects on about half of ET patients, and the effects are moderate. [19]

Second-line

Second-line medications are the anticonvulsants topiramate, gabapentin (as monotherapy) or levetiracetam, or benzodiazepines such as alprazolam.

Third-line

Third-line medications are clonazepam and mirtazapine. [4]

Fourth-line

Theophylline has been used by some practitioners to treat ET, though it may also induce tremor. Its use is debated, though, due to conflicting data on its efficacy. [43] Some evidence shows that low doses may lead to improvement. [44] [45]

Ethanol has shown superior efficacy to those of benzodiazepines in small trials. It improves tremor in small doses and its effects are usually noticeable within 20 minutes for 3–5 hours, but occasionally appears in a rebound tremor augmentation later. [46]

Some systematic reviews of medications for the treatment of ET have been conducted. A 2017 review of topiramate found limited data and low-quality evidence to support its efficacy and the occurrence of treatment-limiting adverse effects, [47] a 2017 review of zonisamide found insufficient information to assess efficacy and safety, [48] and a 2016 review of pregabalin determined the effects to be uncertain due to the low quality of evidence. [49]

Botulinum toxin injection

When medications do not control the tremor or the person does not tolerate medication, C. botulinum toxin, [50] [51] [52] [53] deep brain stimulation, or occupational therapy can be helpful. [4] The electrodes for deep brain stimulation are usually placed in the "tremor center" of the brain, the ventral intermediate nucleus of the thalamus.[ citation needed ]

Ultrasound

Frontal MRI four days after MRgFUS (MRI-guided high-intensity focused ultrasound): Left ventral intermediate nucleus (Vim) thalamotomy. 79-year-old man with essential tremor. MRI-guided HIFU, essential tremor, 10-14 135, pointed.png
Frontal MRI four days after MRgFUS (MRI-guided high-intensity focused ultrasound): Left ventral intermediate nucleus (Vim) thalamotomy. 79-year-old man with essential tremor.

Additionally, MRI-guided high-intensity focused ultrasound is a nonsurgical treatment option for people with essential tremor who are medication refractory. [54] [55] MRI-guided high-intensity focused ultrasound does not achieve healing, but can improve the quality of life by reducing the tremor manifestation. [55] [56] While its long-term effects are not yet established, the improvement in tremor score from baseline was durable at 1 year and 2 years following the treatment. [57] To date, reported adverse events and side effects have been mild to moderate. Possible adverse events include gait difficulties, balance disturbances, paresthesias, headache, skin burns with ulcerations, skin retraction, scars, and blood clots. [54] [55] [58] This procedure is contraindicated in pregnant women, persons who have non-MRI compatible implanted metallic devices, allergy to MR contrast agents, cerebrovascular disease, abnormal bleeding, hemorrhage and/or blood clotting disorders, advanced kidney disease or on dialysis, heart conditions, severe hypertension, and ethanol or substance abuse, among others. [55] The US Food and Drug Administration (FDA) approved Insightec's Exablate Neuro system to treat essential tremor in 2016. [55]

Another treatment for essential tremor is a surgical option; deep brain stimulation is used.

Prognosis

Although essential tremor is often mild, people with severe tremor have difficulty performing many of their routine activities of daily living. [59] [60] ET is generally progressive in most cases (sometimes rapidly, sometimes very slowly), and can be disabling in severe cases. [61] [62] [63]

Epidemiology

ET is one of the most common neurological diseases, with a prevalence around 4% in persons age 40 and older and considerably higher among persons in their 60s, 70s, and 80s, with an estimated 20% of individuals in their 90s and over. [64] Aside from enhanced physiological tremor, it is the most common type of tremor and one of the most commonly observed movement disorders. [65]

Society and culture

Actress Katharine Hepburn (1907–2003) had an essential tremor, possibly inherited from her grandfather, [66] that caused her head—and sometimes her hands—to shake. [67] [68] [69] The tremor was noticeable by the time of her performance in the 1979 film The Corn Is Green , when critics mentioned the "palsy that kept her head trembling". [70] Hepburn's tremor worsened in her later life. [68]

Charles M. Schulz, American cartoonist and creator of the Peanuts comic strip, was affected during the last two decades of his life.

West Virginia Senator Robert Byrd also had essential tremor.

In 2010, musician Daryl Dragon of The Captain and Tennille was diagnosed with essential tremor, with the condition becoming so severe that Dragon was no longer able to play the keyboards. [71]

Director-writer-producer-comedian Adam McKay was diagnosed with essential tremor. [72]

Downton Abbey creator Julian Fellowes has the condition, as does the show's character Charlie Carson. [73]

In 2022, Matthew Caws of Nada Surf and his son made a PSA called "Living with a Mild Essential Tremor". [74]

Research

Harmaline is a widely used model of essential tremor (ET) in rodents. [75] Harmaline is thought to act primarily on neurons in the inferior olive. Olivocerebellar neurons exhibit rhythmic excitatory action when harmaline is applied locally. [75] Harmane or harmaline has been implicated not only in essential tremors, but is also found in greater quantities in the brain fluid of people with Parkinson's disease and cancer. [76] [77] [78] Higher levels of the neurotoxin are associated with greater severity of the tremors. [1] [79] Harmane is particularly abundant in meats, and certain cooking practices (e.g., long cooking times) increase its concentration, [80] [81] [82] but at least one study has shown that harmane blood concentrations do not go up after meat consumption in ET patients with already elevated harmane levels, whereas the control group's harmane levels increase accordingly, suggesting that another factor, such as a metabolic defect, may be responsible for the higher harmane levels in ET patients. [83]

Caprylic acid is being researched as a possible treatment for essential tremor. It has currently been approved by the FDA and designated as GRAS, and is used as a food additive and has been studied as part of a ketogenic diet for treatment of epilepsy in children. Research on caprylic acid as a possible treatment for ET began because researchers recognized that ethanol was effective in reducing tremor, and because of this, they looked into longer-chain alcohols reducing tremor. They discovered that 1-octanol reduced tremor and did not have the negative side effects of ethanol. Pharmacokinetic research on 1-octanol lead to the discovery that 1-octanol metabolized into caprylic acid in the body and that caprylic acid actually was the tremor-reducing agent. [84] Many studies of the effects of caprylic acid on essential tremor have been done, including a dose-escalation study on ET patients [85] and a study testing the effects of caprylic acid on central and peripheral tremor. [19] The dose-escalation study examined doses of 8 mg/kg to 128 mg/kg and determined that these concentrations were safe with mild side effects. The maximum tolerated dose was not reached in this study. The study testing the effects of caprylic acid on central and peripheral tremors determined that caprylic acid reduced both.

Terminology

This type of tremor is often referred to as "kinetic tremor". Essential tremor has been known as "benign essential tremor", but the adjective "benign" has been removed in recognition of the sometimes disabling nature of the disorder. [59] [60]

See also

Related Research Articles

Ataxia is a neurological sign consisting of lack of voluntary coordination of muscle movements that can include gait abnormality, speech changes, and abnormalities in eye movements, that indicates dysfunction of parts of the nervous system that coordinate movement, such as the cerebellum.

<span class="mw-page-title-main">Tremor</span> Involuntary muscle contraction

A tremor is an involuntary, somewhat rhythmic, muscle contraction and relaxation involving oscillations or twitching movements of one or more body parts. It is the most common of all involuntary movements and can affect the hands, arms, eyes, face, head, vocal folds, trunk, and legs. Most tremors occur in the hands. In some people, a tremor is a symptom of another neurological disorder.

<span class="mw-page-title-main">Parkinsonism</span> Medical condition

Parkinsonism is a clinical syndrome characterized by tremor, bradykinesia, rigidity, and postural instability. These are the four motor symptoms found in Parkinson's disease (PD) – after which it is named – dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD), and many other conditions. This set of symptoms occurs in a wide range of conditions and may have many causes, including neurodegenerative conditions, drugs, toxins, metabolic diseases, and neurological conditions other than PD.

<span class="mw-page-title-main">Deep brain stimulation</span> Neurosurgical treatment involving implantation of a brain pacemaker

Deep brain stimulation (DBS) is a surgical procedure that implants a neurostimulator and electrodes which sends electrical impulses to specified targets in the brain responsible for movement control. The treatment is designed for a range of movement disorders such as Parkinson's disease, essential tremor, and dystonia, as well as for certain neuropsychiatric conditions like obsessive-compulsive disorder (OCD) and epilepsy. The exact mechanisms of DBS are complex and not entirely clear, but it is known to modify brain activity in a structured way.

<span class="mw-page-title-main">Dystonia</span> Neurological movement disorder

Dystonia is a neurological hyperkinetic movement disorder in which sustained or repetitive muscle contractions occur involuntarily, resulting in twisting and repetitive movements or abnormal fixed postures. The movements may resemble a tremor. Dystonia is often intensified or exacerbated by physical activity, and symptoms may progress into adjacent muscles.

<span class="mw-page-title-main">Multiple system atrophy</span> Neurodegenerative disorder

Multiple system atrophy (MSA) is a rare neurodegenerative disorder characterized by autonomic dysfunction, tremors, slow movement, muscle rigidity, and postural instability and ataxia. This is caused by progressive degeneration of neurons in several parts of the brain including the basal ganglia, inferior olivary nucleus, and cerebellum.

<span class="mw-page-title-main">Nadolol</span> Non-selective beta blocker used in the treatment of high blood pressure and chest pain

Nadolol, sold under the brand name Corgard among others, is a medication used to treat high blood pressure, heart pain, atrial fibrillation, and some inherited arrhythmic syndromes. It has also been used to prevent migraine headaches and complications of cirrhosis. It is taken orally.

<span class="mw-page-title-main">Progressive supranuclear palsy</span> Medical condition

Progressive supranuclear palsy (PSP) is a late-onset neurodegenerative disease involving the gradual deterioration and death of specific volumes of the brain. The condition leads to symptoms including loss of balance, slowing of movement, difficulty moving the eyes, and cognitive impairment. PSP may be mistaken for other types of neurodegeneration such as Parkinson's disease, frontotemporal dementia and Alzheimer's disease. The cause of the condition is uncertain, but involves the accumulation of tau protein within the brain. Medications such as levodopa and amantadine may be useful in some cases.

Hypokinesia is one of the classifications of movement disorders, and refers to decreased bodily movement. Hypokinesia is characterized by a partial or complete loss of muscle movement due to a disruption in the basal ganglia. Hypokinesia is a symptom of Parkinson's disease shown as muscle rigidity and an inability to produce movement. It is also associated with mental health disorders and prolonged inactivity due to illness, amongst other diseases.

<span class="mw-page-title-main">Spasmodic torticollis</span> Medical condition

Spasmodic torticollis is an extremely painful chronic neurological movement disorder causing the neck to involuntarily turn to the left, right, upwards, and/or downwards. The condition is also referred to as "cervical dystonia". Both agonist and antagonist muscles contract simultaneously during dystonic movement. Causes of the disorder are predominantly idiopathic. A small number of patients develop the disorder as a result of another disorder or disease. Most patients first experience symptoms midlife. The most common treatment for spasmodic torticollis is the use of botulinum toxin type A.

Pantothenate kinase-associated neurodegeneration (PKAN), formerly called Hallervorden–Spatz syndrome, is a genetic degenerative disease of the brain that can lead to parkinsonism, dystonia, dementia, and ultimately death. Neurodegeneration in PKAN is accompanied by an excess of iron that progressively builds up in the brain.

In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief from the symptoms.

<span class="mw-page-title-main">Parkinson's disease</span> Long-term degenerative neurological disorder

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of the central nervous system that affects both the motor system and non-motor systems. The symptoms usually emerge slowly, and as the disease progresses, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia is common in advanced stages.

Signs and symptoms of Parkinson's disease are varied. Parkinson's disease affects movement, producing motor symptoms. Non-motor symptoms, which include dysautonomia, cognitive and neurobehavioral problems, and sensory and sleep difficulties, are also common. When other diseases mimic Parkinson's disease, they are categorized as parkinsonism.

Levodopa-induced dyskinesia (LID) is a form of dyskinesia associated with levodopa (l-DOPA), used to treat Parkinson's disease. It often involves hyperkinetic movements, including chorea, dystonia, and athetosis.

<span class="mw-page-title-main">Parkinsonian gait</span> Type of gait

Parkinsonian gait is the type of gait exhibited by patients with Parkinson's disease (PD). It is often described by people with Parkinson's as feeling like being stuck in place, when initiating a step or turning, and can increase the risk of falling. This disorder is caused by a deficiency of dopamine in the basal ganglia circuit leading to motor deficits. Gait is one of the most affected motor characteristics of this disorder although symptoms of Parkinson's disease are varied.

<span class="mw-page-title-main">History of Parkinson's disease</span> History of Parkinsons disease

The history of Parkinson's disease expands from 1817, when British apothecary James Parkinson published An Essay on the Shaking Palsy, to modern times. Before Parkinson's descriptions, others had already described features of the disease that would bear his name, while the 20th century greatly improved knowledge of the disease and its treatments. PD was then known as paralysis agitans. The term "Parkinson's disease" was coined in 1865 by William Sanders and later popularized by French neurologist Jean-Martin Charcot.

Functional neurologic disorder or functional neurological disorder (FND) is a condition in which patients experience neurological symptoms such as weakness, movement disorders, sensory symptoms, and blackouts. As a functional disorder, there is by definition no known disease process affecting the structure of the body, yet the person experiences symptoms relating to their body function. Symptoms of functional neurological disorders are clinically recognisable, but are not categorically associated with a definable organic disease.

Parkinson's disease dementia (PDD) is dementia that is associated with Parkinson's disease (PD). Together with dementia with Lewy bodies (DLB), it is one of the Lewy body dementias characterized by abnormal deposits of Lewy bodies in the brain.

<span class="mw-page-title-main">Adaptive Deep Brain Stimulation</span> Neurosurgical treatment involving implantation of an adaptive neurostimularot

Adaptive Deep Brain Stimulation (aDBS), also known as Closed Loop Deep Brain stimulation (clDBS), is a neuro-modulatory technique currently under investigation for the treatment of neurodegenerative diseases.

References

  1. 1 2 Louis ED, Zheng W, Mao X, Shungu DC (August 2007). "Blood harmane is correlated with cerebellar metabolism in essential tremor: a pilot study". Neurology. 69 (6): 515–20. doi:10.1212/01.wnl.0000266663.27398.9f. PMID   17679670. S2CID   7612446.
  2. 1 2 "Essential Tremor Treatment at the Johns Hopkins Movement Disorders Center in Baltimore, MD". hopkinsmedicine.org. Retrieved October 27, 2014.
  3. ↑ Bhidayasiri R (December 2005). "Differential diagnosis of common tremor syndromes". Postgraduate Medical Journal. 81 (962): 756–62. doi:10.1136/pgmj.2005.032979. PMC   1743400 . PMID   16344298.
  4. 1 2 3 4 5 6 7 8 9 10 11 12 Abboud H, Ahmed A, Fernandez HH (December 2011). "Essential tremor: choosing the right management plan for your patient". Cleveland Clinic Journal of Medicine. 78 (12): 821–8. doi: 10.3949/ccjm.78a.10178 . PMID   22135272. S2CID   58374.
  5. ↑ Zesiewicz TA, Chari A, Jahan I, Miller AM, Sullivan KL (September 2010). "Overview of essential tremor". Neuropsychiatric Disease and Treatment. 6: 401–8. doi: 10.2147/ndt.s4795 . PMC   2938289 . PMID   20856604.
  6. ↑ "tremor" "at Dorland's Medical Dictionary
  7. ↑ "LINGO1 variant responsible for essential tremors and Parkinson's disease". news-medical.net. 2009-09-02. Retrieved October 27, 2014.
  8. ↑ Shukla AW. "Essential Tremor Information". Unified Health. Retrieved 17 June 2018.
  9. ↑ Louis ED. "Essential Tremor". National Organization for Rare Disorders. Retrieved 17 June 2018.
  10. ↑ Gironell A, Ribosa-Nogué R, Gich I, Marin-Lahoz J, Pascual-Sedano B (2015). "Severity stages in essential tremor: a long-term retrospective study using the glass scale". Tremor and Other Hyperkinetic Movements . 5: 299. doi:10.7916/D8DV1HQC. PMC   4361372 . PMID   25793146.
  11. ↑ Louis ED (September 2001). "Clinical practice. Essential tremor". The New England Journal of Medicine. 345 (12): 887–91. doi:10.1056/nejmcp010928. PMID   11565522.
  12. ↑ Fasano A, Herzog J, Raethjen J, Rose F, Muthuraman M, Volkmann J, Falk D, Elble R, Deuschl G (Dec 2010). "Gait ataxia in essential tremor is differentially modulated by thalamic stimulation". Brain. 133 (Pt 12): 3635–3648. doi: 10.1093/brain/awq267 . PMID   20926368.
  13. ↑ Elble RJ (June 2013). "What is essential tremor?". Curr Neurol Neurosci Rep. 13 (6): 353. doi:10.1007/s11910-013-0353-4. PMC   3674100 . PMID   23591755.
  14. ↑ Ryu DW, Lee SH, Oh YS, An JY, Park JW, Song IU, Lee KS, Kim JS (2017-05-16). "Clinical Characteristics of Parkinson's Disease Developed from Essential Tremor". Journal of Parkinson's Disease. 7 (2): 369–376. doi:10.3233/JPD-160992. PMID   28409750.
  15. 1 2 Rajput AH, Rozdilsky B, Ang L, Rajput A (May 1993). "Significance of parkinsonian manifestations in essential tremor". The Canadian Journal of Neurological Sciences. 20 (2): 114–7. doi: 10.1017/s031716710004765x . PMID   8334571. INIST   4838591.
  16. ↑ Benito-León J, Louis ED, Mitchell AJ, Bermejo-Pareja F (2011). "Elderly-onset essential tremor and mild cognitive impairment: a population-based study (NEDICES)". Journal of Alzheimer's Disease. 23 (4): 727–35. doi:10.3233/JAD-2011-101572. PMID   21304183.
  17. ↑ Benito-León J, Louis ED, Bermejo-Pareja F (May 2006). "Elderly-onset essential tremor is associated with dementia". Neurology. 66 (10): 1500–5. doi:10.1212/01.wnl.0000216134.88617.de. PMID   16717208. S2CID   34434554.
  18. ↑ Klein RD, Kincaid RL, Hodgson AS, Harrison JH, Hillers JK, Cronrath JD (October 1987). "Dietary fiber and early weaning on growth and rumen development of calves". Journal of Dairy Science. 70 (10): 2095–104. doi:10.3168/jds.S0022-0302(87)80259-X. PMC   2824583 . PMID   18043006.
  19. 1 2 3 Cao H, Thompson-Westra J, Hallett M, Haubenberger D (July 2018). "The response of the central and peripheral tremor component to octanoic acid in patients with essential tremor". Clinical Neurophysiology. 129 (7): 1467–1471. doi:10.1016/j.clinph.2018.03.016. PMC   6530908 . PMID   29678370.
  20. ↑ Bracker, Mark D. (December 1994). "A Skin-Deep Diagnosis". The Physician and Sportsmedicine. 22 (12): 79–82. doi:10.1080/00913847.1994.11947721. ISSN   0091-3847. PMID   29272964.
  21. ↑ Deng H, Le W, Jankovic J (June 2007). "Genetics of essential tremor". Brain. 130 (Pt 6): 1456–64. doi: 10.1093/brain/awm018 . PMID   17353225.
  22. ↑ Higgins JJ, Pho LT, Nee LE (November 1997). "A gene (ETM) for essential tremor maps to chromosome 2p22-p25". Movement Disorders. 12 (6): 859–64. doi:10.1002/mds.870120605. PMID   9399207. S2CID   2614579.
  23. ↑ Gulcher JR, Jónsson P, Kong A, Kristjánsson K, Frigge ML, Kárason A, Einarsdóttir IE, Stefánsson H, Einarsdóttir AS, Sigurthoardóttir S, Baldursson S, Björnsdóttir S, Hrafnkelsdóttir SM, Jakobsson F, Benedickz J, Stefánsson K (September 1997). "Mapping of a familial essential tremor gene, FET1, to chromosome 3q13". Nature Genetics. 17 (1): 84–7. doi:10.1038/ng0997-84. PMID   9288103. S2CID   1506516.
  24. ↑ Louis ED (September 2001). "Etiology of essential tremor: should we be searching for environmental causes?". Movement Disorders. 16 (5): 822–9. doi:10.1002/mds.1183. PMID   11746611. S2CID   38809483.
  25. ↑ Louis ED, Vonsattel JP (January 2008). "The emerging neuropathology of essential tremor". Movement Disorders. 23 (2): 174–82. doi:10.1002/mds.21731. PMC   2692583 . PMID   17999421.
  26. 1 2 Mostile G, Jankovic J (October 2010). "Alcohol in essential tremor and other movement disorders". Movement Disorders. 25 (14): 2274–84. doi:10.1002/mds.23240. PMID   20721919. S2CID   39981956.
  27. ↑ Louis ED (October 2009). "Essential tremors: a family of neurodegenerative disorders?". Archives of Neurology. 66 (10): 1202–8. doi:10.1001/archneurol.2009.217. PMC   2762114 . PMID   19822775.
  28. ↑ Louis ED (2014). "'Essential tremor' or 'the essential tremors': is this one disease or a family of diseases?". Neuroepidemiology. 42 (2): 81–9. doi:10.1159/000356351. PMC   3945103 . PMID   24335621.
  29. ↑ Louis ED, Faust PL, Vonsattel JP, Honig LS, Rajput A, Robinson CA, Rajput A, Pahwa R, Lyons KE, Ross GW, Borden S, Moskowitz CB, Lawton A, Hernandez N (December 2007). "Neuropathological changes in essential tremor: 33 cases compared with 21 controls". Brain. 130 (Pt 12): 3297–307. doi: 10.1093/brain/awm266 . PMID   18025031.
  30. ↑ Ghika A, Kyrozis A, Potagas C, Louis ED (2015). "Motor and Non-motor Features: Differences between Patients with Isolated Essential Tremor and Patients with Both Essential Tremor and Parkinson's Disease". Tremor and Other Hyperkinetic Movements . 5: 335. doi:10.7916/D83777WK. PMC   4548968 . PMID   26336614.
  31. ↑ Benito-León J, Sanz-Morales E, Melero H, Louis ED, Romero JP, Rocon E, Malpica N (November 2019). "Graph theory analysis of resting-state functional magnetic resonance imaging in essential tremor". Human Brain Mapping. 40 (16): 4686–4702. doi:10.1002/hbm.24730. PMC   6865733 . PMID   31332912.
  32. ↑ National Toxicology Program (June 2012). "NTP monograph on health effects of low-level lead" (PDF). NTP Monograph. US Department of Health and Human Services (1): xiii, xv–148. PMID   23964424.
  33. ↑ Delay C, Tremblay C, Brochu E, Paris-Robidas S, Emond V, Rajput AH, Rajput A, Calon F (November 2014). "Increased LINGO1 in the cerebellum of essential tremor patients". Movement Disorders. 29 (13): 1637–47. doi:10.1002/mds.25819. PMID   24531928. S2CID   27331090.
  34. ↑ Kuo SH, Tang G, Louis ED, Ma K, Babji R, Balatbat M, Cortes E, Vonsattel JP, Yamamoto A, Sulzer D, Faust PL (June 2013). "Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau". Acta Neuropathologica. 125 (6): 879–89. doi:10.1007/s00401-013-1108-7. PMC   3663903 . PMID   23543187.
  35. ↑ Paris-Robidas S, Brochu E, Sintes M, Emond V, Bousquet M, Vandal M, Pilote M, Tremblay C, Di Paolo T, Rajput AH, Rajput A, Calon F (January 2012). "Defective dentate nucleus GABA receptors in essential tremor". Brain. 135 (Pt 1): 105–16. doi: 10.1093/brain/awr301 . PMID   22120148.
  36. ↑ Vilariño-Güell C, Soto-Ortolaza AI, Rajput A, Mash DC, Papapetropoulos S, Pahwa R, Lyons KE, Uitti RJ, Wszolek ZK, Dickson DW, Farrer MJ, Ross OA (February 2011). "MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy". Neurology. 76 (7): 670–2. doi:10.1212/WNL.0b013e31820c30c1. PMC   3053340 . PMID   21321341.
  37. ↑ Louis ED, Dure LS, Pullman S (September 2001). "Essential tremor in childhood: a series of nineteen cases". Movement Disorders. 16 (5): 921–3. doi:10.1002/mds.1182. PMID   11746623. S2CID   30848508.
  38. ↑ Bain PG, Findley LJ, Thompson PD, Gresty MA, Rothwell JC, Harding AE, Marsden CD (August 1994). "A study of hereditary essential tremor". Brain. 117 (4): 805–24. doi:10.1093/brain/117.4.805. PMID   7922467.
  39. ↑ Cohen O, Pullman S, Jurewicz E, Watner D, Louis ED (2003). "Rest tremor in essential tremor patients: Prevalence, clinical correlates, and electrophysiological characteristics". Arch Neurol. 60 (3): 405–410. doi: 10.1001/archneur.60.3.405 . PMID   12633153.
  40. ↑ Biary N, Koller W, Langenberg P (December 1990). "Correlation between essential tremor and migraine headache". Journal of Neurology, Neurosurgery, and Psychiatry. 53 (12): 1060–2. doi:10.1136/jnnp.53.12.1060. PMC   488315 . PMID   2292698.
  41. ↑ P N Leigh; D Jefferson; A Twomey; C D Marsden (Aug 1985). "Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol". J Neurol Neurosurg Psychiatry. 46 (8): 510–15. doi:10.1136/jnnp.46.8.710. PMC   1027523 . PMID   1027523. S2CID   12506398.
  42. ↑ Mostile, Giovanni; Jankovic, Joseph (2010). "Alcohol in essential tremor and other movement disorders". Movement Disorders. 25 (14): 2274–2284. doi:10.1002/mds.23240. ISSN   1531-8257. PMID   20721919. S2CID   39981956.
  43. ↑ Zesiewicz TA, Elble R, Louis ED, Hauser RA, Sullivan KL, Dewey RB, Ondo WG, Gronseth GS, Weiner WJ (June 2005). "Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 64 (12): 2008–20. doi: 10.1212/01.WNL.0000163769.28552.CD . PMID   15972843.
  44. ↑ Mally J, Stone TW (June 1991). "The effect of theophylline on essential tremor: the possible role of GABA". Pharmacology Biochemistry and Behavior. 39 (2): 345–9. doi:10.1016/0091-3057(91)90190-D. PMID   1946576. S2CID   1344534.
  45. ↑ Mally J, Stone TW (October 1995). "Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol". Journal of the Neurological Sciences. 132 (2): 129–32. doi:10.1016/0022-510X(95)00128-O. PMID   8543937. S2CID   21810329.
  46. ↑ Ondo W (2016). "Essential Tremor: What We Can Learn from Current Pharmacotherapy". Tremor and Other Hyperkinetic Movements . 6: 356. doi:10.7916/D8K35TC3. PMC   4790207 . PMID   26989572.
  47. ↑ Bruno E, Nicoletti A, Quattrocchi G, Allegra R, Filippini G, Colosimo C, Zappia M (April 2017). "Topiramate for essential tremor". The Cochrane Database of Systematic Reviews. 2017 (4): CD009683. doi:10.1002/14651858.CD009683.pub2. PMC   6478240 . PMID   28409827.
  48. ↑ Bruno E, Nicoletti A, Filippini G, Quattrocchi G, Colosimo C, Zappia M (August 2017). "Zonisamide for essential tremor". The Cochrane Database of Systematic Reviews. 2017 (8): CD009684. doi:10.1002/14651858.CD009684.pub2. PMC   6483684 . PMID   28836659.
  49. ↑ Bruno E, Nicoletti A, Quattrocchi G, Filippini G, Colosimo C, Zappia M (October 2016). "Pregabalin for essential tremor". The Cochrane Database of Systematic Reviews. 10 (7): CD009682. doi:10.1002/14651858.CD009682.pub2. PMC   6461190 . PMID   27763691.
  50. ↑ Zakin E, Simpson D (November 2017). "Botulinum Toxin in Management of Limb Tremor". Toxins. 9 (11): 365. doi: 10.3390/toxins9110365 . PMC   5705980 . PMID   29125566.
  51. ↑ Samotus O, Rahimi F, Lee J, Jog M (2016). "Functional Ability Improved in Essential Tremor by IncobotulinumtoxinA Injections Using Kinematically Determined Biomechanical Patterns - A New Future". PLOS ONE. 11 (4): e0153739. Bibcode:2016PLoSO..1153739S. doi: 10.1371/journal.pone.0153739 . PMC   4839603 . PMID   27101283.
  52. ↑ Samotus O, Lee J, Jog M (2017). "Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections". PLOS ONE. 12 (6): e0178670. Bibcode:2017PLoSO..1278670S. doi: 10.1371/journal.pone.0178670 . PMC   5460844 . PMID   28586370.
  53. ↑ Samotus O, Kumar N, Rizek P, Jog M (January 2018). "Botulinum Toxin Type A Injections as Monotherapy for Upper Limb Essential Tremor Using Kinematics". The Canadian Journal of Neurological Sciences. 45 (1): 11–22. doi: 10.1017/cjn.2017.260 . PMID   29157315.
  54. 1 2 Rohani M, Fasano A (2017). "Focused Ultrasound for Essential Tremor: Review of the Evidence and Discussion of Current Hurdles". Tremor and Other Hyperkinetic Movements . 7: 462. doi:10.7916/D8Z89JN1. PMC   5425801 . PMID   28503363.
  55. 1 2 3 4 5 FDA News Release. "FDA approves first MRI-guided focused ultrasound device to treat essential tremor", FDA , July 11, 2016
  56. ↑ Aharonson V, Postema M, Gebbie R, Van Der Merwe J, Schlesinger I (2023). "Sobel edge detection for quantifying the effectiveness of focused ultrasound thalamotomy for tremor relief". Current Directions in Biomedical Engineering. 9 (1): 17–20. doi: 10.1515/cdbme-2023-1005 .
  57. ↑ Chang JW, Park CK, Lipsman N, Schwartz ML, Ghanouni P, Henderson JM, Gwinn R, Witt J, Tierney TS, Cosgrove GR, Shah BB, Abe K, Taira T, Lozano AM, Eisenberg HM, Fishman PS, Elias WJ (December 2017). "A Prospective Trial of Magnetic Resonance guided Focused Ultrasound Thalamotomy for Essential Tremor: Results at the 2-year Follow-up". Annals of Neurology. 83 (1): 107–114. doi:10.1002/ana.25126. PMID   29265546. S2CID   4437809.
  58. ↑ Hedera P (February 2017). "Emerging strategies in the management of essential tremor". Therapeutic Advances in Neurological Disorders (Review). 10 (2): 137–148. doi:10.1177/1756285616679123. PMC   5367648 . PMID   28382111.
  59. 1 2 Bain PG, Mally J, Gresty M, Findley LJ (November 1993). "Assessing the impact of essential tremor on upper limb function". Journal of Neurology. 241 (1): 54–61. doi:10.1007/bf00870673. PMID   8138823. S2CID   9502687.
  60. 1 2 Louis ED, Barnes L, Albert SM, Cote L, Schneier FR, Pullman SL, Yu Q (September 2001). "Correlates of functional disability in essential tremor". Movement Disorders. 16 (5): 914–20. doi:10.1002/mds.1184. PMID   11746622. S2CID   9540572.
  61. ↑ Critchley M (1949). "Observations on essential (heredofamilial) tremor". Brain. 72 (2): 113–139. doi:10.1093/brain/72.2.113. PMID   18136705.
  62. ↑ Busenbark KL, Nash J, Nash S, Hubble JP, Koller WC (1991). "Is essential tremor benign?". Neurology. 41 (12): 1982–1983. doi:10.1212/wnl.41.12.1982. PMID   1745359. S2CID   41199748.
  63. ↑ Louis ED, Ford B, Barnes LF (2000). "Clinical subtypes of essential tremor". Arch Neurol. 57 (8): 1194–1198. doi: 10.1001/archneur.57.8.1194 . PMID   10927801.
  64. ↑ Louis ED, Ferreira JJ (April 2010). "How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor". Movement Disorders. 25 (5): 534–41. doi:10.1002/mds.22838. PMID   20175185. S2CID   32051975.
  65. ↑ Benito-León J, Louis ED (December 2006). "Essential tremor: emerging views of a common disorder". Nature Clinical Practice Neurology. 2 (12): 666–78, quiz 2p following 691. doi:10.1038/ncpneuro0347. PMID   17117170. S2CID   5902956.
  66. ↑ Healy, David (director) (January 18, 1993). Katharine Hepburn: All About Me. Turner Home Entertainment.
  67. ↑ Claiborne RC (July 22, 2003). "Q & A; Head and Hand Tremors". The New York Times. Retrieved November 3, 2013.
  68. 1 2 Berg AS (2004) [2003]. Kate Remembered: Katharine Hepburn, a personal biography. London: Pocket. p. 260. ISBN   978-0-7434-1563-7.
  69. ↑ Conova S (January 29, 2003). "Stopping essential tremor". In Vivo. Columbia University Health Sciences. 2 (2).
  70. ↑ Dickens H (1990) [1971]. The Films of Katharine Hepburn . New York City, NY: Carol Publishing Group. p.  31. ISBN   978-0-8065-1175-7.
  71. ↑ Grow, Kory (2019-01-03). "Daryl Dragon, Captain and Tennille's Captain, Dead at 76". Rolling Stone. Retrieved 2022-03-02.
  72. ↑ Goodyear D (14 March 2011). "Hollywood Shadows". The New Yorker. Retrieved 2018-12-13.
  73. ↑ "Downton Abbey creator reveals reason he gave Mr Carson a tremor". Breaking News.ie. November 19, 2019. Retrieved August 20, 2020.
  74. ↑ "Essential Tremor". Matthewcaws.com. Retrieved April 9, 2022.
  75. 1 2 Miwa H (2007). "Rodent models of tremor". Cerebellum. 6 (1): 66–72. doi:10.1080/14734220601016080. PMID   17366267. S2CID   24179439.
  76. ↑ Kuhn W, Müller T, Grosse H, Rommelspacher H (1996). "Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients". Journal of Neural Transmission. 103 (12): 1435–40. doi:10.1007/bf01271257. PMID   9029410. S2CID   21230301.
  77. ↑ Pfau W, Skog K (March 2004). "Exposure to beta-carbolines norharman and harman". Journal of Chromatography B. 802 (1): 115–26. doi: 10.1016/j.jchromb.2003.10.044 . PMID   15036003.
  78. ↑ Louis ED, Pellegrino KM, Factor-Litvak P, Rios E, Jiang W, Henchcliffe C, Zheng W (September 2008). "Cancer and blood concentrations of the comutagen harmane in essential tremor". Movement Disorders. 23 (12): 1747–51. doi:10.1002/mds.22084. PMC   2597456 . PMID   18709680.
  79. ↑ Louis ED, Factor-Litvak P, Gerbin M, Slavkovich V, Graziano JH, Jiang W, Zheng W (March 2011). "Blood harmane, blood lead, and severity of hand tremor: evidence of additive effects". Neurotoxicology. 32 (2): 227–32. doi:10.1016/j.neuro.2010.12.002. PMC   3073713 . PMID   21145352.
  80. ↑ Louis ED, Jiang W, Gerbin M, Viner AS, Factor-Litvak P, Zheng W (2012). "Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New York". Journal of Toxicology and Environmental Health. Part A. 75 (12): 673–83. doi:10.1080/15287394.2012.688485. PMC   3412610 . PMID   22757671.
  81. ↑ Louis ED, Zheng W, Jiang W, Bogen KT, Keating GA (June 2007). "Quantification of the neurotoxic beta-carboline harmane in barbecued/grilled meat samples and correlation with level of doneness". Journal of Toxicology and Environmental Health. Part A. 70 (12): 1014–9. doi:10.1080/15287390601172015. PMC   4993204 . PMID   17497412.
  82. ↑ Louis ED, Keating GA, Bogen KT, Rios E, Pellegrino KM, Factor-Litvak P (2008). "Dietary epidemiology of essential tremor: meat consumption and meat cooking practices". Neuroepidemiology. 30 (3): 161–6. doi:10.1159/000122333. PMC   2821442 . PMID   18382115.
  83. ↑ Louis ED, Zheng W, Applegate L, Shi L, Factor-Litvak P (August 2005). "Blood harmane concentrations and dietary protein consumption in essential tremor". Neurology. 65 (3): 391–6. doi:10.1212/01.wnl.0000172352.88359.2d. PMC   4993192 . PMID   16087903.
  84. ↑ Haubenberger D, McCrossin G, Lungu C, Considine E, Toro C, Nahab FB, Auh S, Buchwald P, Grimes GJ, Starling J, Potti G, Scheider L, Kalowitz D, Bowen D, Carnie A, Hallett M (March 2013). "Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study". Neurology. 80 (10): 933–40. doi:10.1212/WNL.0b013e3182840c4f. PMC   3653213 . PMID   23408867.
  85. ↑ Voller B, Lines E, McCrossin G, Tinaz S, Lungu C, Grimes G, Starling J, Potti G, Buchwald P, Haubenberger D, Hallett M (April 2016). "Dose-escalation study of octanoic acid in patients with essential tremor". The Journal of Clinical Investigation. 126 (4): 1451–7. doi:10.1172/JCI83621. PMC   4811161 . PMID   26927672.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.